TRANSCAT INC (TRNS) Fundamental Analysis & Valuation

NASDAQ:TRNS • US8935291075

Current stock price

83.22 USD
-0.1 (-0.12%)
Last:

This TRNS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. TRNS Profitability Analysis

1.1 Basic Checks

  • TRNS had positive earnings in the past year.
  • TRNS had a positive operating cash flow in the past year.
  • TRNS had positive earnings in each of the past 5 years.
  • TRNS had a positive operating cash flow in each of the past 5 years.
TRNS Yearly Net Income VS EBIT VS OCF VS FCFTRNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

1.2 Ratios

  • The Return On Assets of TRNS (1.67%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 2.66%, TRNS is in line with its industry, outperforming 42.55% of the companies in the same industry.
  • TRNS's Return On Invested Capital of 3.14% is on the low side compared to the rest of the industry. TRNS is outperformed by 61.70% of its industry peers.
  • TRNS had an Average Return On Invested Capital over the past 3 years of 6.00%. This is below the industry average of 9.04%.
Industry RankSector Rank
ROA 1.67%
ROE 2.66%
ROIC 3.14%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
TRNS Yearly ROA, ROE, ROICTRNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 2.47%, TRNS is in line with its industry, outperforming 46.81% of the companies in the same industry.
  • TRNS's Profit Margin has improved in the last couple of years.
  • TRNS has a Operating Margin (5.60%) which is in line with its industry peers.
  • TRNS's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 32.45%, TRNS perfoms like the industry average, outperforming 59.57% of the companies in the same industry.
  • TRNS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.6%
PM (TTM) 2.47%
GM 32.45%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
TRNS Yearly Profit, Operating, Gross MarginsTRNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. TRNS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TRNS is destroying value.
  • The number of shares outstanding for TRNS has been increased compared to 1 year ago.
  • TRNS has more shares outstanding than it did 5 years ago.
  • TRNS has a worse debt/assets ratio than last year.
TRNS Yearly Shares OutstandingTRNS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
TRNS Yearly Total Debt VS Total AssetsTRNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • TRNS has an Altman-Z score of 3.85. This indicates that TRNS is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.85, TRNS is in the better half of the industry, outperforming 65.96% of the companies in the same industry.
  • The Debt to FCF ratio of TRNS is 4.02, which is a neutral value as it means it would take TRNS, 4.02 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 4.02, TRNS is doing good in the industry, outperforming 70.21% of the companies in the same industry.
  • TRNS has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.34, TRNS is in the better half of the industry, outperforming 61.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 4.02
Altman-Z 3.85
ROIC/WACC0.33
WACC9.54%
TRNS Yearly LT Debt VS Equity VS FCFTRNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.3 Liquidity

  • TRNS has a Current Ratio of 2.21. This indicates that TRNS is financially healthy and has no problem in meeting its short term obligations.
  • TRNS has a Current ratio of 2.21. This is comparable to the rest of the industry: TRNS outperforms 59.57% of its industry peers.
  • TRNS has a Quick Ratio of 1.85. This is a normal value and indicates that TRNS is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.85, TRNS is doing good in the industry, outperforming 78.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.85
TRNS Yearly Current Assets VS Current LiabilitesTRNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. TRNS Growth Analysis

3.1 Past

  • TRNS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.19%.
  • TRNS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.36% yearly.
  • Looking at the last year, TRNS shows a quite strong growth in Revenue. The Revenue has grown by 17.45% in the last year.
  • TRNS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.97% yearly.
EPS 1Y (TTM)-9.19%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%4%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%25.62%

3.2 Future

  • TRNS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.15% yearly.
  • Based on estimates for the next years, TRNS will show a quite strong growth in Revenue. The Revenue will grow by 8.45% on average per year.
EPS Next Y25.77%
EPS Next 2Y21.67%
EPS Next 3Y17.45%
EPS Next 5Y17.15%
Revenue Next Year19.68%
Revenue Next 2Y13.45%
Revenue Next 3Y9.11%
Revenue Next 5Y8.45%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
TRNS Yearly Revenue VS EstimatesTRNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
TRNS Yearly EPS VS EstimatesTRNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

2

4. TRNS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 49.54, TRNS can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, TRNS is valued a bit more expensive than 63.83% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.18. TRNS is valued rather expensively when compared to this.
  • With a Price/Forward Earnings ratio of 38.24, TRNS can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of TRNS is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of TRNS to the average of the S&P500 Index (37.96), we can say TRNS is valued inline with the index average.
Industry RankSector Rank
PE 49.54
Fwd PE 38.24
TRNS Price Earnings VS Forward Price EarningsTRNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TRNS is valued a bit more expensive than 65.96% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of TRNS indicates a somewhat cheap valuation: TRNS is cheaper than 72.34% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 31.22
EV/EBITDA 20.44
TRNS Per share dataTRNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TRNS does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as TRNS's earnings are expected to grow with 17.45% in the coming years.
PEG (NY)1.92
PEG (5Y)7.79
EPS Next 2Y21.67%
EPS Next 3Y17.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TRNS Dividend Analysis

5.1 Amount

  • No dividends for TRNS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TRNS Fundamentals: All Metrics, Ratios and Statistics

TRANSCAT INC

NASDAQ:TRNS (4/14/2026, 2:10:07 PM)

83.22

-0.1 (-0.12%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-03
Earnings (Next)05-18
Inst Owners101.52%
Inst Owner Change-0.86%
Ins Owners1.03%
Ins Owner Change0.71%
Market Cap776.44M
Revenue(TTM)319.69M
Net Income(TTM)7.89M
Analysts80
Price Target103.36 (24.2%)
Short Float %6.38%
Short Ratio3.59
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-19.05%
Min EPS beat(2)-23.53%
Max EPS beat(2)-14.58%
EPS beat(4)2
Avg EPS beat(4)2.74%
Min EPS beat(4)-23.53%
Max EPS beat(4)46.44%
EPS beat(8)4
Avg EPS beat(8)4.49%
EPS beat(12)7
Avg EPS beat(12)2.23%
EPS beat(16)8
Avg EPS beat(16)1.87%
Revenue beat(2)2
Avg Revenue beat(2)0.8%
Min Revenue beat(2)0.17%
Max Revenue beat(2)1.44%
Revenue beat(4)3
Avg Revenue beat(4)1.06%
Min Revenue beat(4)-1.01%
Max Revenue beat(4)3.66%
Revenue beat(8)4
Avg Revenue beat(8)-1.56%
Revenue beat(12)6
Avg Revenue beat(12)-1.1%
Revenue beat(16)8
Avg Revenue beat(16)-0.67%
PT rev (1m)0%
PT rev (3m)-2.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.23%
EPS NY rev (1m)-2.29%
EPS NY rev (3m)-14.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.31%
Valuation
Industry RankSector Rank
PE 49.54
Fwd PE 38.24
P/S 2.43
P/FCF 31.22
P/OCF 19.77
P/B 2.62
P/tB N/A
EV/EBITDA 20.44
EPS(TTM)1.68
EY2.02%
EPS(NY)2.18
Fwd EY2.61%
FCF(TTM)2.67
FCFY3.2%
OCF(TTM)4.21
OCFY5.06%
SpS34.26
BVpS31.81
TBVpS-0.29
PEG (NY)1.92
PEG (5Y)7.79
Graham Number34.67
Profitability
Industry RankSector Rank
ROA 1.67%
ROE 2.66%
ROCE 4.1%
ROIC 3.14%
ROICexc 3.17%
ROICexgc 10.29%
OM 5.6%
PM (TTM) 2.47%
GM 32.45%
FCFM 7.78%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
ROICexc(3y)6.37%
ROICexc(5y)6.98%
ROICexgc(3y)14.95%
ROICexgc(5y)15.39%
ROCE(3y)7.84%
ROCE(5y)8.8%
ROICexgc growth 3Y-9.42%
ROICexgc growth 5Y-3.25%
ROICexc growth 3Y-18.51%
ROICexc growth 5Y-11.8%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
F-Score4
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 4.02
Debt/EBITDA 2.34
Cap/Depr 57.97%
Cap/Sales 4.51%
Interest Coverage 250
Cash Conversion 91.87%
Profit Quality 315.12%
Current Ratio 2.21
Quick Ratio 1.85
Altman-Z 3.85
F-Score4
WACC9.54%
ROIC/WACC0.33
Cap/Depr(3y)85.02%
Cap/Depr(5y)89.69%
Cap/Sales(3y)4.65%
Cap/Sales(5y)4.54%
Profit Quality(3y)129.96%
Profit Quality(5y)134.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-9.19%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%4%
EPS Next Y25.77%
EPS Next 2Y21.67%
EPS Next 3Y17.45%
EPS Next 5Y17.15%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%25.62%
Revenue Next Year19.68%
Revenue Next 2Y13.45%
Revenue Next 3Y9.11%
Revenue Next 5Y8.45%
EBIT growth 1Y-18.8%
EBIT growth 3Y8.38%
EBIT growth 5Y11.83%
EBIT Next Year192.65%
EBIT Next 3Y47.62%
EBIT Next 5Y32.49%
FCF growth 1Y34.44%
FCF growth 3Y51.16%
FCF growth 5Y38.93%
OCF growth 1Y31.51%
OCF growth 3Y30.31%
OCF growth 5Y27.52%

TRANSCAT INC / TRNS Fundamental Analysis FAQ

What is the fundamental rating for TRNS stock?

ChartMill assigns a fundamental rating of 4 / 10 to TRNS.


Can you provide the valuation status for TRANSCAT INC?

ChartMill assigns a valuation rating of 2 / 10 to TRANSCAT INC (TRNS). This can be considered as Overvalued.


Can you provide the profitability details for TRANSCAT INC?

TRANSCAT INC (TRNS) has a profitability rating of 5 / 10.


What is the valuation of TRANSCAT INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for TRANSCAT INC (TRNS) is 49.54 and the Price/Book (PB) ratio is 2.62.